Skip to content
10-Q

Quarterly Report

Decoy Therapeutics Inc. DCOY

0001615219-25-000164

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 5.86M sh
Shares Diluted Q3 2025 · Sep 30, 2025 481.59K sh
Shares Diluted Q3 2025 · Sep 30, 2025 246.74K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 85.46K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 53.43K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.69M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$3.78M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.81M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.43M
Stockholders Equity Q3 2025 · Sep 30, 2025 $4.25M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$829.72K
Stockholders Equity Q3 2025 · Mar 31, 2025 $61.87K
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.51M
Stockholders Equity Q3 2025 · Sep 30, 2024 $2.92M
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.38M
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.65M
Stockholders Equity Q3 2025 · Dec 31, 2023 $5.29M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.85M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.51M
Current Assets Q3 2025 · Sep 30, 2025 $6.06M
Current Assets Q3 2025 · Dec 31, 2024 $2.99M
Total Assets Q3 2025 · Sep 30, 2025 $6.1M
Total Assets Q3 2025 · Dec 31, 2024 $3.02M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.81
Eps Diluted Q3 2025 · Sep 30, 2025 −$14.35
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$11.38
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$76.96
Eps Basic Q3 2025 · Sep 30, 2025 −$1.81
Eps Basic Q3 2025 · Sep 30, 2025 −$14.35
Eps Basic restated Q3 2025 · Sep 30, 2024 −$11.38
Eps Basic restated Q3 2025 · Sep 30, 2024 −$76.96
Sga Expense Q3 2025 · Sep 30, 2025 $833.3K
Sga Expense Q3 2025 · Sep 30, 2025 $3.33M
Sga Expense Q3 2025 · Sep 30, 2024 $869.24K
Sga Expense Q3 2025 · Sep 30, 2024 $3.65M
Rd Expense Q3 2025 · Sep 30, 2025 $61.83K
Rd Expense Q3 2025 · Sep 30, 2025 $253.74K
Rd Expense Q3 2025 · Sep 30, 2024 $137.23K
Rd Expense Q3 2025 · Sep 30, 2024 $594.68K
Net Income Q3 2025 · Sep 30, 2025 −$873.47K
Net Income Q3 2025 · Sep 30, 2025 −$3.54M
Net Income Q3 2025 · Jun 30, 2025 −$957.83K
Net Income Q3 2025 · Mar 31, 2025 −$1.71M
Net Income Q3 2025 · Sep 30, 2024 −$972.12K
Net Income Q3 2025 · Sep 30, 2024 −$4.11M
Net Income Q3 2025 · Jun 30, 2024 −$1.42M
Net Income Q3 2025 · Mar 31, 2024 −$1.72M
Operating Income Q3 2025 · Sep 30, 2025 −$895.13K
Operating Income Q3 2025 · Sep 30, 2025 −$3.58M
Operating Income Q3 2025 · Sep 30, 2024 −$1.01M
Operating Income Q3 2025 · Sep 30, 2024 −$4.25M